Cannell & Spears’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-66,887
| Closed | -$690K | – | 225 |
|
|
2023
Q3 | $690K | Sell |
66,887
-368
| -0.5% | -$3.49K | 0.06% | 111 |
|
|
2023
Q2 | $555K | Sell |
67,255
-170,119
| -72% | -$1.02M | 0.05% | 134 |
|
|
2023
Q1 | $1.33M | Sell |
237,374
-6,371
| -3% | -$36.5K | 0.12% | 81 |
|
|
2022
Q4 | $1.21M | Sell |
243,745
-429,071
| -64% | -$1.77M | 0.12% | 83 |
|
|
2022
Q3 | $3.23M | Sell |
672,816
-4,554
| -0.7% | -$19.5K | 0.32% | 50 |
|
|
2022
Q2 | $1.74M | Buy |
677,370
+2,320
| +0.3% | +$8.7K | 0.16% | 67 |
|
|
2022
Q1 | $3.89M | Buy |
675,050
+58,622
| +10% | +$526K | 0.29% | 48 |
|
|
2021
Q4 | $9.25M | Sell |
616,428
-95,977
| -13% | -$1.75M | 0.62% | 30 |
|
|
2021
Q3 | $18.7M | Buy |
712,405
+26,865
| +4% | +$990K | 1.35% | 26 |
|
|
2021
Q2 | $34.3M | Sell |
685,540
-2,739
| -0.4% | -$123K | 2.46% | 17 |
|
|
2021
Q1 | $31.7M | Buy |
688,279
+305,846
| +80% | +$14.6M | 2.45% | 18 |
|
|
2020
Q4 | $16.4M | Buy |
382,433
+301,088
| +370% | +$11.4M | 1.37% | 24 |
|
|
2020
Q3 | $3.32M | Buy |
81,345
+75,347
| +1,256% | +$3.75M | 0.32% | 48 |
|
|
2020
Q2 | $328K | Sell |
5,998
-156
| -3% | -$8.92K | 0.03% | 154 |
|
|
2020
Q1 | $322K | Buy |
+6,154
| New | +$333K | 0.04% | 142 |
|
Other funds holding TRHC
Cannell & Spears's TRHC Position: Q4 2023 in Review
Cannell & Spears sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q4 2023, closing a stake of 66,887 shares — an estimated $690K sold.
Cannell & Spears first reported a position in TRHC in Q1 2020 and held it in 15 quarters. The position peaked at $34.3M in Q2 2021. 1 fund tracked by Wall St. Rank holds TRHC as of Q4 2023.
- Cannell & Spears reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Cannell & Spears sold 66,887 Tabula Rasa HealthCare, Inc. Common Stock shares in Q4 2023, an estimated $690K.
- Cannell & Spears first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q1 2020 and held it in 15 quarters.
- Cannell & Spears's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $34.3M in Q2 2021.
- 1 fund tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q4 2023.
Based on Cannell & Spears's 13F filing for Q4 2023, filed 14 Feb 2024.